Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
concealed cardiomyopathy in sudden childhood death translation from molecular autopsy to family assessment
Original title: “Concealed cardiomyopathy in sudden childhood death: translation from molecular autopsy to family assessment.”
antiarrhythmic drug therapy in cardiomyopathies a comparative synthesis of guidelines and consensus documents
Original title: “Antiarrhythmic Drug Therapy in Cardiomyopathies: A Comparative Synthesis of Guidelines and Consensus Documents.”
genetic architecture of pediatric cardiomyopathies assessed by whole exome sequencing insights into early onset and syndromic forms
Original title: “Genetic Architecture of Pediatric Cardiomyopathies Assessed by Whole-Exome Sequencing: Insights Into Early-Onset and Syndromic Forms.”
high protein diet ameliorates cardiomyopathy in a cardiac specific agl knockout mouse model association with upregulated hepatic gluconeogenesis
Original title: “High-Protein Diet Ameliorates Cardiomyopathy in a Cardiac-Specific AGL Knockout Mouse Model: Association With Upregulated Hepatic Gluconeogenesis.”
dutch cardiomyopathy registry dcr rationale and registry design
Original title: “The Dutch cardiomyopathy registry (DCR); rationale and registry design.”
After an FDA advisory committee voted 9-3 on Wednesday against recommending Capricor Therapeutics’ Duchenne muscular dystrophy cardiomyopathy drug for approval, stakeholders allege an “ulterior motive” and “biased intentions.”
Original title: “Capricor CEO won’t rule out legal action against FDA after negative adcomm”
effects of sglt2 inhibition on incident heart failure in carriers of cardiomyopathy associated genetic variants
Original title: “Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants.”
global model for symptomatic obstructive hypertrophic cardiomyopathy to assess the cost effectiveness of mavacamten results from a dutch societal perspective
Original title: “A global model for symptomatic obstructive hypertrophic cardiomyopathy to assess the cost-effectiveness of mavacamten: results from a Dutch societal perspective.”
novel scn5a variant associated with flecainide responsive multifocal ventricular arrhythmia and recovered cardiomyopathy
Original title: “Novel SCN5A variant associated with flecainide-responsive multifocal ventricular arrhythmia and recovered cardiomyopathy.”
low albumin heavy hearts role of hypoalbuminemia in infiltrative cardiomyopathies a narrative review
Original title: “Low Albumin, Heavy Hearts: Role of Hypoalbuminemia in Infiltrative Cardiomyopathies: A Narrative Review.”
classification of cardiomyopathies bringing order to complexity
Original title: “Classification of cardiomyopathies: bringing order to complexity.”
clinical usefulness of genetic diagnosis in early onset cardiomyopathies
Original title: “Clinical usefulness of genetic diagnosis in early-onset cardiomyopathies.”